Adults living with eosinophilic granulomatosis with polyangiitis (#EGPA) could take part in a Phase 2 clinical trial of NS-229, an investigational JAK1 inhibitor.
Learn more and explore participation: https://ow.ly/nm9w50X65UE
This year’s Kindness Over Muscular Dystrophy Annual Benefit was nothing short of inspiring!
From local bites and brews to exciting auctions and raffles, the energy in the room was matched only by the generosity of those supporting the Duchenne and Becker community. ✨
Say hello to Lori Amels, one of our new Key Account Managers on the Commercial Sales team!
With a strong background across gene therapy, ophthalmology and neurology, Lori’s expertise is matched by her passion for helping patients and families.